Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction

Trends in Cardiovascular Medicine

Volumn 12, Issue 3, 2002, Pages 97-101

  D'Armiento, Jeanine ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN FIBER; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGENASE; FIBRONECTIN; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE;

AGING; BIOLOGICAL MODEL; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; HEART DISEASE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SHORT SURVEY; STRAIN DIFFERENCE; WILD TYPE; ZYMOGRAPHY;

EID: 0036247785     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(01)00160-8     Document Type: Review

References (49)

1. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation
2. Matrix metalloproteinases: A review
3. Morphometry of the aging heart
4. Integrins-mediated cell-matrix interactions in heart development and in disease
5. Inducible collagenolytic activity in isolated perfused rat hearts
6. Collagenase activity in the normal rat myocardium
7. Collagen loss in the stunned myocardium
8. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
9. Signal transduction by integrin receptors for extracellular matrix: Cooperative processing of extracellular information
10. Age related changes of the collagen network of the human heart
11. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
12. Collagen chain mRNA's in isolated heart cells from the young and adult rats
13. Collagen and the myocardium: Fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression
14. Transgenic animal models: New avenues in cardiovascular physiology
15. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
16. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links
17. Animal models of human cardiovascular disease, heart failure and hypertrophy
18. Collagen Degradation in the Heart
19. Interstitial Collagenases
20. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction
21. Apo E knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis
22. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices
23. Matrix metalloproteinases: Structures, evolution, and diversification
24. Metalloproteinases and their inhibitors in matrix remodeling
25. The distribution of collagenase in normal rat tissues
26. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
27. Matrix metalloproteinase inhibition attenuates left ventriclar remodeling and dysfunction in a rat model of progressive heart function
28. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat
29. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart
30. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice
31. Matrix metalloproteinase inhibition during the development of congestive heart failure: Effects on left ventricular dimensions and function
32. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure
33. Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: Changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans
34. Collagen degradation in ischaemic rat hearts
35. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
36. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts
37. Differential gene expression of extracellular matrix components in dilated cardiomyopathy
38. Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: Differential expression with collagenase-1 (matrix metalloproteinase-1)
39. Cardiac interstitium in health and disease: The fibrillar collagen network
40. Remodeling and reparation of the cardiovascular system
41. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system
42. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium
43. Inadequate collagen tethers in dilated cardiopathy
44. Fibrillar collagen and remodeling of dilated canine left ventricle
45. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction